ASMB Stock Price and Chart NASDAQ:ASMB

MarketBeat has tracked 35 news articles for Assembly Biosciences this week, compared to 18 articles on an average week. 0.58% of the outstanding shares of Assembly Biosciences have been sold short. Assembly Biosciences has only been the subject of 1 research reports in the past 90 days. Take your analysis to the next level with our full suite of features, known and used by millions throughout the trading world. Potential 200% playAnother play that will only pay the paytient ones.

It allows the user to better focus on the stocks that are the best fit for his or her personal trading style. 8 employees have rated Assembly Biosciences Chief Executive Officer John McHutchison on Glassdoor.com. John McHutchison has an approval rating of 80% among the company’s employees. 76.0% of employees surveyed would recommend working at Assembly Biosciences to a friend. Biden’s disturbing new government program may be worse than Obama’s.

This is a buy and forget situation I believe as this will take at the least several months to recover. We’d like to share more about how we work and what drives our day-to-day business. Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams.

Assembly Biosciences downgraded to hold from buy at Truist

Historical and current end-of-day data provided by FACTSET. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. Intraday data delayed at least 15 minutes or per exchange requirements. The heavy selling pressure might have exhausted for Assembly Biosciences as it is technically in oversold territory now. In addition to this technical measure, strong agreement among Wall Street analysts in revising…

In the Morningstar Style Box, large-cap names account for the largest 70% of U.S. stocks, mid-cap names account for the largest 70–90%, and small-cap names are the remaining 10% of companies. Dividend yield allows investors, particularly those interested in dividend-paying stocks, to compare the relationship between a stock’s price and how it rewards stockholders through dividends. The formula for calculating dividend yield is to divide the annual dividend paid per share by the stock price. The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock.

H.C. Wainwright Sticks to Their Hold Rating for Assembly Biosciences (ASMB)

This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.27% per year. These returns cover a period from January 1, 1988 through April 3, 2023. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations.

• Morningstar Quantitative ratings for equities are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.
• It’s calculated by averaging the closing stock price over the previous 50 trading days.
• Assembly Biosciences has received a 74.27% net impact score from Upright.
• Assembly Biosciences’ stock was trading at $1.30 at the beginning of 2023.

Provide specific products and services to you, such as portfolio management or data aggregation. A stock’s beta measures how closely tied its price movements have been to the performance of the overall market. Style is an investment factor that has a meaningful impact on investment risk and returns. Style is calculated by combining value and growth scores, which are first individually calculated.

New Strong Buy Stocks for August 4th

Assembly Biosciences saw a increase in short interest in April. As of April 15th, there was short interest totaling 302,700 shares, an increase of 84.5% from the March 31st total of 164,100 shares. Based on an average daily volume of 258,900 shares, the short-interest ratio is presently 1.2 days. Assembly Biosciences’ stock was trading at $1.30 at the beginning of 2023. Since then, ASMB shares have decreased by 20.0% and is now trading at $1.04.

downstream operations Inc 52 week low is $0.77 as of April 29, 2023. 52 week high is the highest price of a stock in the past 52 weeks, or one year. Assembly Biosciences Inc 52 week high is $2.42 as of April 29, 2023.

Other market data may be delayed by 15 minutes or more. EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. The technique has proven to be very useful for finding positive surprises.

Products

https://1investing.in/ has been upgraded to a Zacks Rank #1 , reflecting growing optimism about the company’s earnings prospects. Zacks Earnings ESP looks to find companies that have recently seen positive earnings estimate revision activity. The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season. The scores are based on the trading styles of Value, Growth, and Momentum. There’s also a VGM Score (‘V’ for Value, ‘G’ for Growth and ‘M’ for Momentum), which combines the weighted average of the individual style scores into one score. The Style Scores are a complementary set of indicators to use alongside the Zacks Rank.

• Real-time analyst ratings, insider transactions, earnings data, and more.
• The idea is that more recent information is, generally speaking, more accurate and can be a better predictor of the future, which can give investors an advantage in earnings season.
• Transparency is how we protect the integrity of our work and keep empowering investors to achieve their goals and dreams.
• The industry with the best average Zacks Rank would be considered the top industry , which would place it in the top 1% of Zacks Ranked Industries.

On average, they expect the company’s share price to reach $2.17 in the next year. This suggests a possible upside of 108.3% from the stock’s current price. View analysts price targets for ASMB or view top-rated stocks among Wall Street analysts. High-growth stocks tend to represent the technology, healthcare, and communications sectors.

Assembly Biosciences to Present Data in Four Poster Presentations at Upcoming AASLD The Liver Meeting®

The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share . It can also be calculated by dividing the company’s Market Cap by the Net Profit. Real-time analyst ratings, insider transactions, earnings data, and more. Assembly Biosciences has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts …

© 2023 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided ‘as-is’ and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart’s disclaimer. Upgrade to MarketBeat All Access to add more stocks to your watchlist. One share of ASMB stock can currently be purchased for approximately $1.04. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Mizuho Securities analyst Salim Syed maintained a Buy rating on Assembly Biosciences (ASMB – Research Report) today and set a price target of $3.00. The company’s shares opened today at $1.36.Syed covers the Healthcare sec… Assembly Biosciences has a news sentiment score of 0.09.

A former bank regulator is blowing the whistle on Biden’s frightening plan to take over your money. Sign-up to receive the latest news and ratings for Assembly Biosciences and its competitors with MarketBeat’s FREE daily newsletter. The P/E ratio of Assembly Biosciences is -0.54, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. In the past three months, Assembly Biosciences insiders have sold more of their company’s stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $21,108.00 in company stock.

Our investment management business generates asset-based fees, which are calculated as a percentage of assets under management. We also sell both admissions and sponsorship packages for our investment conferences and advertising on our websites and newsletters. Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Wainwright maintained a Hold rating on Assembly Biosciences (ASMB – Research Report), with a price target of $2.50. The company’s shares closed yesterday at $2.16.According to …

How big is Assembly Biosciences Inc?

A hold rating indicates that analysts believe investors should maintain any existing positions they have in ASMB, but not buy additional shares or sell existing shares. Assembly Biosciences, Inc., a clinical-stage biotechnology company, discovers and develops therapeutic candidates for the treatment of hepatitis B virus infection in the United States. The company’s lead product candidate is Vebicorvir, which as completed Phase 2 clinical trials to treat patients with chronic HBV infection. It is also developing ABI-H3733 that has completed Phase 1a clinical study, and ABI-4334, which is in pre-clinical trials for the treatment of HBV. The company has collaboration agreements with BeiGene, Ltd. and Arbutu… At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors.

This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 to -2 . This is a lower news sentiment than the 0.65 average news sentiment score of Medical companies. Assembly Biosciences has received a consensus rating of Hold. The company’s average rating score is 2.33, and is based on 1 buy rating, 2 hold ratings, and no sell ratings.

They rarely distribute dividends to shareholders, opting for reinvestment in their businesses. More value-oriented stocks tend to represent financial services, utilities, and energy stocks. These are established companies that reliably pay dividends. Market capitalization is calculated by taking a company’s share price and multiplying it by the total number of shares.